HistoSonics website screenshot

HistoSonics

HistoSonics is a medical device company commercializing histotripsy, a non-invasive, non-thermal and non-ionizing sonic beam therapy that uses focused ultrasound to form a controlled bubble cloud which mechanically destroys and liquefies targeted tissue at a sub-cellular level. Its robotically assisted Edison Histotripsy System received U.S. FDA marketing authorization through the De Novo Classification Request process in October 2023 for the non-invasive destruction of liver tumors, making it the first histotripsy platform authorized anywhere in the world, and has since added CE Mark authorization in Europe and an FDA submission covering kidney tumors. The underlying science originated with researchers at the University of Michigan, and the company maintains clinical partnerships with the University of Michigan and the University of Wisconsin. HistoSonics publishes no public developer portal, API documentation, SDK, or machine-readable API specification; its public web surface is a marketing, clinical-evidence, physician-education and eIFU site rather than an API platform.

HistoSonics is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Health Technology, and Oncology.

HistoSonics’ developer surface includes product news and 16 more developer resources.

11.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0
0 APIs
CompanyMedical DevicesHealthcareHealth TechnologyOncologyFocused UltrasoundSurgical RoboticsMedical Imaging

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0
Composite quality — 11.1/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Commercial Clarity 3.6 / 17
Operational Transparency 0.0 / 11
Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 2.6 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/histosonics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Histosonics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Learn 1

Tutorials, courses, talks, and written guidance

Operate 1

Status, limits, changes, and where to get help

Commercial 2

Pricing, plans, and the legal terms of use

Company 8

The organization behind the API

Scroll for all 8

Other 3

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: histosonics
image: https://histosonics.com/wp-content/uploads/2023/10/logo.svg
name: HistoSonics
description: HistoSonics is a medical device company commercializing histotripsy, a non-invasive, non-thermal and non-ionizing
  sonic beam therapy that uses focused ultrasound to form a controlled bubble cloud which mechanically destroys and liquefies
  targeted tissue at a sub-cellular level. Its robotically assisted Edison Histotripsy System received U.S. FDA marketing
  authorization through the De Novo Classification Request process in October 2023 for the non-invasive destruction of liver
  tumors, making it the first histotripsy platform authorized anywhere in the world, and has since added CE Mark authorization
  in Europe and an FDA submission covering kidney tumors. The underlying science originated with researchers at the University
  of Michigan, and the company maintains clinical partnerships with the University of Michigan and the University of Wisconsin.
  HistoSonics publishes no public developer portal, API documentation, SDK, or machine-readable API specification; its public
  web surface is a marketing, clinical-evidence, physician-education and eIFU site rather than an API platform.
url: https://raw.githubusercontent.com/api-evangelist/histosonics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: no-public-api-surface
specificationVersion: '0.20'
created: '2026-08-04'
modified: '2026-08-04'
tags:
- Company
- Medical Devices
- Healthcare
- Health Technology
- Oncology
- Focused Ultrasound
- Surgical Robotics
- Medical Imaging
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  name: HistoSonics domain security probe
  url: security/histosonics-domain-security.yml
- type: LLMsTxt
  name: HistoSonics llms.txt
  url: llms/histosonics-llms.txt
- type: Website
  name: HistoSonics
  url: https://histosonics.com/
- type: About
  name: About HistoSonics
  url: https://histosonics.com/about-us/
- type: News
  name: HistoSonics News
  url: https://histosonics.com/resources/news/
- type: BlogFeeds
  name: HistoSonics news RSS feed
  url: https://histosonics.com/resources/news/feed/
- type: Contact
  name: Let's Talk
  url: https://histosonics.com/lets-talk/
- type: Careers
  name: Careers at HistoSonics
  url: https://histosonics.com/careers/
- type: Education
  name: HistoSonics Education
  url: https://histosonics.com/education/
- type: Events
  name: HistoSonics Events
  url: https://histosonics.com/events/
- type: Videos
  name: HistoSonics Resource Videos
  url: https://histosonics.com/resources/videos/
- type: Patents
  name: HistoSonics Patents
  url: https://histosonics.com/patents/
- type: TermsOfService
  name: Terms of Use
  url: https://histosonics.com/terms-of-use/
- type: PrivacyPolicy
  name: Privacy Policy
  url: https://histosonics.com/privacy-policy/
- type: LinkedIn
  name: HistoSonics on LinkedIn
  url: https://www.linkedin.com/company/histosonics-inc-/
- type: Twitter
  name: HistoSonics on X
  url: https://twitter.com/histosonics
- type: InvestorProfile
  name: HistoSonics on Forge Global (secondary market)
  url: https://forgeglobal.com/histosonics_stock/
x-enrichment:
  date: '2026-08-04'
  status: minimal
  artifacts_added: 3
  pass: local-v1
  note: Full contract discovery run (STEP 0b) against histosonics.com and myhistotripsy.com; no API host, docs host, or developer
    subdomain resolves. No OpenAPI/Swagger, GraphQL, MCP, AsyncAPI, agent card, llms.txt, SDK, or /.well-known/ document exists.
    HistoSonics is a medical device manufacturer, not an API producer.